6,678 trials
Hiv
Primary: The Level of Raltegravir Alone or Raltegravir /Lamivudine Required in the Plasma, Vagina and Rectum for 100% ex Vivo Protection From HIV — NA; 669.90; 265.10; 979.8 ng/mL
Arthropathy Shoulder
Primary: Patient Pain Scores — 4.0; 2.8 score on a scale — p=.0197
Leukemia
Primary: the Overall Survival of APL Patients Treated With Retinoic Acid Receptor Alpha (ATRA) and Arsenic Trioxide (ATO) Based Trial — 1; 0; 0; 0 participants — p=<0.05
Surgical Conditions
Primary: Leiden Surgical Rating Scale — 4.8; 4.8 score on a scale — p=0.94
Lacerations · Pain, Procedural · LET
Primary: Visual Analog Scale Pain Score — 16; 16 mm
Knee Osteoarthritis · Knee Pain Chronic · Opioid Use
Primary: Opioid Consumption — 287.0; 281.1 morphine equivalents
Lumbar Spondylosis · Lumbar Spondylolisthesis · Adult Degenerative Lumbar Scoliosis
Primary: Quality of Spine Fusion, Measured by the Number of Participants With Complete Spine Fusion at 1 Year — 11; 6 Participants
Healthy Volunteers · Diabetes Mellitus, Type 2 · Overweight
Primary: Intensity of Injection Site Pain — 5.6; 11.5 Score on a scale — p=<0.0001
Pain, Postoperative · Crohn Disease · Inflammatory Bowel Diseases
Primary: Cumulative 48-hour Post Surgical Opiate Use (Oral Morphine Equivalent) — 47; 69 Oral morphine equivalents
Diarrhea
Primary: Percent of Patients With Return Toward a Normal Fecal Bile Acid Pattern — 100 percentage of participants
Type 2 Diabetes
Primary: Epicardial Fat Thickness — 8.6; 8.0; 7.2; 7.4 mm
Parkinson Disease
Primary: Change From Baseline to Week 18 in Parkinson's Disease Sleep Scale 2nd Version (PDSS-2) Total Score — -13.7; -14.4 Score on a scale — p=0.688
Thoracolumbar Scoliosis
Primary: Opioid Usage — 0.41; 0.47; 0.58; 0.55 mg/kg
Temporomandibular Disorder
Primary: Pain Evaluation — 6.38; 6.93; 5.76; 5.49 score on a scale
HHT · Hereditary Hemorrhagic Telangiectasia · Epistaxis
Primary: Change in Epistaxis Severity Score (ESS) — -2.27; -1.16; -2.27; -1.01 score on a scale — p=0.111